Financial Disclosures: None reported.
Funding/Support: Dr Beasley's HBV vaccine studies were sponsored by Merck Sharp & Dohme, which provided the vaccine and operational costs but not investigator salaries or other personal benefits. Other studies by Dr Beasley referenced herein were sponsored by the National Institutes of Health (NIH) and/or the government of Taiwan. HBIG used in his studies was provided by several HBIG manufacturers, such as Cutter Laboratories or purchased using funds from one or more of the sources mentioned.
Additional Contributions: The studies in Taiwan were conducted with the permission of the Taiwan government and under institutional review board approval following NIH guidelines.
Disclaimer: The opinions herein are solely those of the author. All information and opinions published by the author represented the work of his team without restrictions by Merck Sharp & Dohme, which did not review the papers prior to publication.